Bristol Myers Squibb (BMY)

Change in Working Capital

-$624.00M

Quarterly · Period ending: · USD

BMY logo

BMY Change in Working Capital

Latest reported-$624.00M
BMY Quarterly Change in Working Capital (-$109.00M → -$624.00M)
High-resolution chart · PNG

BMY change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
-624,000,000
-3,002,000,000
-1,654,000,000
3,055,000,000
15,000,000
-1,871,000,000
1,276,000,000
1,707,000,000
-2,371,000,000
198,000,000
855,000,000
291,000,000
-1,700,000,000
-1,360,000,000
-458,000,000
164,000,000
-1,573,000,000
-362,000,000
-56,000,000
649,000,000
-1,416,000,000
-435,000,000
-154,000,000
-1,302,000,000
1,150,000,000
1,279,000,000
1,845,000,000
922,000,000
637,000,000
-390,000,000
645,000,000
-345,000,000
460,000,000
-584,000,000
2,201,000,000
128,000,000
-21,000,000
-720,000,000
69,000,000
325,000,000
-620,000,000
-941,000,000
548,000,000
-173,000,000
-853,000,000
-532,000,000
-104,000,000
398,000,000
184,000,000
-481,000,000
498,000,000
208,000,000
899,000,000
-1,117,000,000
-3,417,000,000
483,000,000
232,000,000
-1,207,000,000
335,000,000
586,000,000
-122,000,000
-814,000,000
519,000,000
228,000,000
-120,000,000
-793,000,000
612,000,000
252,000,000
-460,000,000
-379,000,000
199,000,000
290,000,000
74,000,000
-446,000,000
30,000,000
-249,000,000
136,000,000
-75,000,000
222,000,000
296,000,000
-344,000,000
-814,000,000
-91,000,000
-112,000,000
-901,000,000
200,000,000
-299,000,000
-331,000,000
-93,000,000
115,000,000
1,080,000,000
-541,000,000
175,000,000
-783,000,000
-34,000,000
-551,000,000
-266,000,000
-2,299,000,000
1,177,000,000
-34,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.